These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18368691)

  • 21. Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
    Watson AD; Church DB
    Aust Vet J; 1995 Nov; 72(11):401-3. PubMed ID: 8929183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
    Atkins CE; Keene BW; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards NJ; Fox PR; Lehmkuhl LB; Luethy MW; Meurs KM; Petrie JP; Pipers FS; Rosenthal SL; Sidley JA; Straus JH
    J Am Vet Med Assoc; 2007 Oct; 231(7):1061-9. PubMed ID: 17916031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy.
    Borgarelli M; Haggstrom J
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):651-63. PubMed ID: 20610017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digitalis versus diuretics: an individualized approach.
    Wood GL
    Vet Clin North Am; 1978 May; 8(2):245-56. PubMed ID: 685068
    [No Abstract]   [Full Text] [Related]  

  • 25. Current concepts in clinical therapeutics: congestive heart failure.
    Klamerus KJ
    Clin Pharm; 1986 Jun; 5(6):481-98. PubMed ID: 2872992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do diuretics differ in terms of clinical outcome in congestive heart failure?
    Follath F
    Eur Heart J; 1998 Dec; 19 Suppl P():P5-8. PubMed ID: 9886706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Individual glycoside therapy using serum concentration determination in canine heart failure].
    Staudacher G
    Dtsch Tierarztl Wochenschr; 1989 May; 96(6):308-10. PubMed ID: 2758985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
    Wolf J; Gerlach N; Weber K; Klima A; Wess G
    J Vet Cardiol; 2012 Sep; 14(3):399-408. PubMed ID: 22858663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic and clinical effects of milrinone in dogs with myocardial failure.
    Kittleson MD; Pipers FS; Knauer KW; Keister DM; Knowlen GG; Miner WS
    Am J Vet Res; 1985 Aug; 46(8):1659-64. PubMed ID: 4037492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of human spironolactone in dogs with heart failure.
    Broadfoot F; McGuire P
    Vet Rec; 2008 Apr; 162(14):460. PubMed ID: 18390864
    [No Abstract]   [Full Text] [Related]  

  • 31. Short-term effects of ecadotril in dogs with induced congestive heart failure.
    Olivier NB; Kutas SM; Beals S; Hanson B; Windram S
    Am J Vet Res; 2000 Mar; 61(3):333-8. PubMed ID: 10714529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of serum chloride concentration in dogs with congestive heart failure.
    Adin D; Atkins C; Londoño L; Del Nero B
    J Vet Intern Med; 2021 Jan; 35(1):51-57. PubMed ID: 33305873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
    Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of human spironolactone in dogs with heart failure.
    Whitehead M
    Vet Rec; 2008 May; 162(18):599. PubMed ID: 18453385
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of human spironolactone in dogs with heart failure.
    Watson P
    Vet Rec; 2008 May; 162(18):599. PubMed ID: 18453386
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors contributing to the decision for euthanasia of dogs with congestive heart failure.
    Mallery KF; Freeman LM; Harpster NK; Rush JE
    J Am Vet Med Assoc; 1999 Apr; 214(8):1201-4. PubMed ID: 10212683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
    de Andrade JN; Christopher Orton E; Boon J; Nishimori CT; Olivaes C; Camacho AA
    J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.